Human Gene Therapy 
when is it ethical to begin?’. New F.ngland Journal of Medicine 303, 1293- 
1297. 
Brinster, R. L. et al. : 1983, ‘Expression of a microinjected immunoglobulin gene 
in the spleen of transgenic mice’. Nature 306, 332—336. 
Fletcher, J. C.: 1985, ‘Ethical issues in and beyond prospective clinical trials of 
human gene therapy’. Journal of Medicine and Philosophy 10, 293—309. 
Goldstein, J. L. and Brown, M. S.: 1983, ‘Familial hypercholesterolemia’, in 
J. B. Stanbury et al. (eds.). The Metabolic Basis of Inherited Disease , 5th 
edition, McGraw-Hill, New York, pp. 672 — 712. 
Hammer, R. E. et al.: 1984, ‘Partial correction of murine hereditary growth 
disorder by germ-line incorporation of a new gene’, Nature 31 1, 65—67. 
Joyner, A. et al.: 1983, ‘Retrovirus transfer of a bacterial gene into mouse 
haematopoietic progenitor cells’, Nature 305, 556—558. 
Lacy, E. et al.: 1983, ‘A foreign 0-globin gene in transgenic mice: integration at 
abnormal chromosomal positions and expression in inappropriate tissues’, 
Cell 34, 343-358. 
Miller, A. D. et al.: 1984, ‘Expression of a retrovirus encoding human HPRT in 
mice’, Science 225, 630-632. 
Williams, D. A. et al.: 1984, ‘Introduction of new genetic material into pluri- 
potent haematopoietic stem cells of the mouse’, Nature 310, 476—480. 
Willis, R. C. et al.: 1984, ‘Partial phenotypic correction of human Lesch-Nyhan 
(hypoxan thine -guanine phosphoribosyl transferase-deficient) lymphoblasts 
with a transmissible retroviral vector’, Journal of Biological Chemistry 259, 
7842-7849. 
[334] 
Recombinant DNA Research. Volume 12 
